When prime minister Narasimha Rao handpicked Manmohan Singh as finance minister in 1991, it was an audacious gamble. Here was a technocrat—soft-spoken, unassuming and seemingly ill-suited to the cut-throat world of politics. But Rao's instincts were correct. Facing a near-catastrophic balance-of-payments crisis, Singh unlocked India with reforms, dismantled decades-old red tape and gave wings to the nation's entrepreneurial spirit. His economic liberalization laid the foundation for modern India, his diplomacy expanded its global influence, and his integrity inspired trust in public life.
His 1991 Budget speech is now the stuff of legend: "No power on Earth can stop an idea whose time has come." These words, delivered in his trademark monotone, masked the monumental shift they heralded. Singh's reforms opened India to global markets, attracting investments, boosting industries, and laying the groundwork for the IT revolution. Millions were lifted out of poverty, and India's GDP growth began its ascent to global prominence.
An economist of rare brilliance, a statesman of unshakable integrity, and a man of quiet yet unyielding resolve, Singh leaves behind a legacy that defies the noisy rhetoric of politics. His life story—one of humble beginnings, transformative achievements, and steadfast principles—mirrors the aspirations of a modern, self-assured India.
Diese Geschichte stammt aus der December 28, 2024-Ausgabe von Mint Kolkata.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der December 28, 2024-Ausgabe von Mint Kolkata.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
Intel's grim lesson for Boeing: Sometimes Mr. Fix-It is too late
One day, fickle investors are applauding business-school alumni for paying big dividends and slashing costs. The next, they're demanding that engineers take over to make up for lost innovation.
Beijing Pushes to Use China-Made Chips in Its Electric Vehicles
Not long ago, almost all the chips in Chinese cars relied on manufacturing by foreign firms
Will the Guardrails of US Democracy Hold?
America's democratic institutions withstood, if only barely, Donald Trump's first presidency, but will they do so again?
RIL's acquisitions: $13 bn spent in 5 yrs
Billionaire Mukesh Ambani's Reliance Industries Ltd (RIL) has spent $13 billion on acquisitions in the past five years across new energy, telecom, retail and media business to script a pivot away from core oil and petrochemicals business to clean energy and consumer-facing verticals.
Sebi introduces MF Lite framework
Index and exchange-traded funds (ETFs) to schemes sponsored by private equity funds will be eligible to be covered under the MF Lite framework on meeting certain conditions as the market regulator aims to simplify the operations of passively managed mutual funds.
Gold Heads for Biggest Gain Since 2010 in Mixed Year for Metals
Gold is heading for its biggest gain in 14 years, with a 27% advance fueled by US monetary easing, sustained geopolitical risks and a wave of purchases by central banks.
Interest on PPF, NSC unchanged
The government on Tuesday left the interest rates unchanged on various small savings schemes, including Public Provident Fund (PPF) and National Savings Certificate (NSC), for the fourth straight quarter beginning 1 January 2023 and ending 31 March 2025.
Rupee declines to record closing low
The rupee declined to a record closing low for the sixth consecutive session on Tuesday, weighed down by a decline in most Asian currencies alongside expectations that it is headed for more losses in 2025.
NaBFID invests ₹745 cr in NDR InvIT
The National Bank for Financing Infrastructure and Development (NaBFID) has invested ₹745 crore in long-term bonds issued by NDR InvIT, the company said on Tuesday.
Drugmaker Anthem files for IPO
Indian contract drugmaker Anthem Biosciences filed for a ₹33.95 billion ($397 million) initial public offering (IPO), draft papers showed on Tuesday, at the fag end of what has been a red-hot year for companies listing on the stock market.
